Cardiovascular Drug Agents
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
FORMULATION, CHARACTERIZATION AND IN
... dosage form. The present study is based on Esomeprazole Magnesium Trihydrate (ESM) as a model drug. Esomeprazole Magnesium Trihydrate is a drug prescribed to treat disorders caused by excess stomach acid. Available as the brand Nexium Esomeprazole Magnesium Trihydrate is a proton pump inhibitor (PPI ...
... dosage form. The present study is based on Esomeprazole Magnesium Trihydrate (ESM) as a model drug. Esomeprazole Magnesium Trihydrate is a drug prescribed to treat disorders caused by excess stomach acid. Available as the brand Nexium Esomeprazole Magnesium Trihydrate is a proton pump inhibitor (PPI ...
Q17 Classify the calcium channel blockers and
... Available in PO tablets (30mg) and IV Comes in immediate or sustained release solution200mcg/ml tablets of varying strengths and IV solution for injection ...
... Available in PO tablets (30mg) and IV Comes in immediate or sustained release solution200mcg/ml tablets of varying strengths and IV solution for injection ...
amoxicillin/clavulanic acid
... CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: CLAVAMOX (amoxicillin trihydrate/clavulanate potassium) is an orally administered formulation comprised of the broad-spectrum antibiotic Amoxi® (amoxicillin trihydrate) and the ß-lactamase in ...
... CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. DESCRIPTION: CLAVAMOX (amoxicillin trihydrate/clavulanate potassium) is an orally administered formulation comprised of the broad-spectrum antibiotic Amoxi® (amoxicillin trihydrate) and the ß-lactamase in ...
Summer Fellow Poster template
... Future Research: Following characterization, tissue culturing will be used to determine whether it is worth pursuing in vivo studies. We will utilize fibroblasts as our culture cell because studies have shown that adhesion cells are very similar to fibroblasts in both growth and connection [1]. If t ...
... Future Research: Following characterization, tissue culturing will be used to determine whether it is worth pursuing in vivo studies. We will utilize fibroblasts as our culture cell because studies have shown that adhesion cells are very similar to fibroblasts in both growth and connection [1]. If t ...
women
... normal cell activity COX –2 enzyme – produces prostaglandins at site of inflammation Most NXAIDS are nonselective in targeting COX-1 & COX-2 ...
... normal cell activity COX –2 enzyme – produces prostaglandins at site of inflammation Most NXAIDS are nonselective in targeting COX-1 & COX-2 ...
Volume of distribution and the effects of plasma protein and tissue
... The 500 mg of Drug B appears to distribute into a larger volume, leaving less in the plasma. Thus, the plasma concentration is smaller. So, if the doses are the same, why is there a 10-fold difference in Vd for these two drugs in the same patient? -Cp depends on dose and the extent of distribution. ...
... The 500 mg of Drug B appears to distribute into a larger volume, leaving less in the plasma. Thus, the plasma concentration is smaller. So, if the doses are the same, why is there a 10-fold difference in Vd for these two drugs in the same patient? -Cp depends on dose and the extent of distribution. ...
Companion animal praCtiCe Medical management of
... pregnant bitches has not been evaluated as yet and so cannot be recommended. It should not be used in dogs less than 16 weeks of age as some studies have noted bone marrow hypoplasia in young puppies receiving maropitant. This product is highly protein bound and may compete with other highly bound d ...
... pregnant bitches has not been evaluated as yet and so cannot be recommended. It should not be used in dogs less than 16 weeks of age as some studies have noted bone marrow hypoplasia in young puppies receiving maropitant. This product is highly protein bound and may compete with other highly bound d ...
INDAPAMIDE-GA
... specific sites. In blood, it is highly bound to red blood cells (80%) and, more specifically, to carbonic acid anhydrase (98%) without having any significant inhibiting activity on this enzyme. In plasma, it is relatively highly bound to plasma proteins (79%). It is also taken up to a significant de ...
... specific sites. In blood, it is highly bound to red blood cells (80%) and, more specifically, to carbonic acid anhydrase (98%) without having any significant inhibiting activity on this enzyme. In plasma, it is relatively highly bound to plasma proteins (79%). It is also taken up to a significant de ...
- ISpatula
... in Jordan because until now it is not accepted by FDA according to its safety. And there are a several studies which indicate that Stevioside is possessing mutagenic activity. So, due to mutagenicity, Stevioside is not yet accepted by FDA. It is available in market in japan and in many countries as ...
... in Jordan because until now it is not accepted by FDA according to its safety. And there are a several studies which indicate that Stevioside is possessing mutagenic activity. So, due to mutagenicity, Stevioside is not yet accepted by FDA. It is available in market in japan and in many countries as ...
Treatments for Diabetes Mellitus
... PPAR alpha and PPAR gamma • PPAR alphas are lipoprotein regulators expressed in catabolic tissues such as the liver, kidney, heart and skeletal muscles • PPAR gamma is primarily expressed in adipose tissue, however, it is occasionally active in skeletal muscle, kidney, and intestine • PPAR gamma’s ...
... PPAR alpha and PPAR gamma • PPAR alphas are lipoprotein regulators expressed in catabolic tissues such as the liver, kidney, heart and skeletal muscles • PPAR gamma is primarily expressed in adipose tissue, however, it is occasionally active in skeletal muscle, kidney, and intestine • PPAR gamma’s ...
Non Steroidal Anti-inflammatory Drugs (NSAIDs)
... Diclofenac • Short half life (1‐2 hrs), high 1st pass metab., accumulates in synovial fluid after oral admn.. • GI S/E : in about 20% pt. Severe effects like GI distress, GI bleeding, gastric ulceration less frequent than other NSAIDs and similar to celecoxib. • High doses impairs renal functio ...
... Diclofenac • Short half life (1‐2 hrs), high 1st pass metab., accumulates in synovial fluid after oral admn.. • GI S/E : in about 20% pt. Severe effects like GI distress, GI bleeding, gastric ulceration less frequent than other NSAIDs and similar to celecoxib. • High doses impairs renal functio ...
Chemistry in every day life - Kendriya Vidyalaya, Bailey Road, Patna
... ENZYMES AS DRUG TARGETS CATALYTIC ACTION OF EN ZYMESEnzymes have active sites which hold the substrate molecule .it can be attracted by reacting molecules. (b) Substrate is bonded to active sites through hydrogen bonds, ionic bonds, Vander Waal or dipole – dipole interactions. (ii) DRUG- ENZYME INTE ...
... ENZYMES AS DRUG TARGETS CATALYTIC ACTION OF EN ZYMESEnzymes have active sites which hold the substrate molecule .it can be attracted by reacting molecules. (b) Substrate is bonded to active sites through hydrogen bonds, ionic bonds, Vander Waal or dipole – dipole interactions. (ii) DRUG- ENZYME INTE ...
EVALUATION OF ANTIEPILEPTIC AND NOOTROPIC EFFECTS OF
... were a stronger inhibitory effect on the bacteria. Minimum inhibitory concentration values for both bacteria Leuconostoc mesenteroides and Lactobacillus delbruekiiranged between 1. 5 mg/ml and 1.75 mg/ml29. 2. Hari Om Saxena, Uzma Faridi, Suchita Srivastava, Kumar J. K, Darokar M. P, Suaib et.al. Pr ...
... were a stronger inhibitory effect on the bacteria. Minimum inhibitory concentration values for both bacteria Leuconostoc mesenteroides and Lactobacillus delbruekiiranged between 1. 5 mg/ml and 1.75 mg/ml29. 2. Hari Om Saxena, Uzma Faridi, Suchita Srivastava, Kumar J. K, Darokar M. P, Suaib et.al. Pr ...
FileList Convert a pdf file!
... 85. Mebendazole, an anthe lmintic drug has one group at 5-position in the Benz imidazole structure. It is A) –S-CH2 - CH2 – CH3 B) – S – Ph C) Ph – SO2 – D) Ph – CO – 86. The bio logical half life of a drug A) Is a constant ph ysical property of the drug B) Is a constant che mical property of the dr ...
... 85. Mebendazole, an anthe lmintic drug has one group at 5-position in the Benz imidazole structure. It is A) –S-CH2 - CH2 – CH3 B) – S – Ph C) Ph – SO2 – D) Ph – CO – 86. The bio logical half life of a drug A) Is a constant ph ysical property of the drug B) Is a constant che mical property of the dr ...
Beating Bacteria - Activity Version 2 - Instruction
... The results (Potency score) show how good the various compounds are at killing bacteria in a petri dish. The Side effect scores were obtained by studying the effects of the compounds on suspensions of isolated human cells in test tubes. The “standard” which is referred to is being used in an experim ...
... The results (Potency score) show how good the various compounds are at killing bacteria in a petri dish. The Side effect scores were obtained by studying the effects of the compounds on suspensions of isolated human cells in test tubes. The “standard” which is referred to is being used in an experim ...
Differential induction of hepatic drug
... II is bioaccumulated in rat liver and kidney (Misra and Sharma, 1997). No chronic toxicity and no carcinogenic effects were observed in long-term exposure studies in mice (Parker et al., 1983; Cabral and Galendo, 1990) and rats (Parker et al., 1984). However, high fenvalerate concentrations induce m ...
... II is bioaccumulated in rat liver and kidney (Misra and Sharma, 1997). No chronic toxicity and no carcinogenic effects were observed in long-term exposure studies in mice (Parker et al., 1983; Cabral and Galendo, 1990) and rats (Parker et al., 1984). However, high fenvalerate concentrations induce m ...
Public Assessment Report Scientific discussion Ursochol 600
... functions explained. The current strength is an addition to the range of other strengths marketed by the MAH (150 mg, 300 mg and 450 mg). The drug product is fully dose proportional to the other three strengths. No clinical studies with the proposed strength have been performed, instead dissolution ...
... functions explained. The current strength is an addition to the range of other strengths marketed by the MAH (150 mg, 300 mg and 450 mg). The drug product is fully dose proportional to the other three strengths. No clinical studies with the proposed strength have been performed, instead dissolution ...
A Patient of Poisoning in ICU
... (BOH) in the tubular lumen into the charged salt. (A-/B+) – The charged particle is lipid-insoluble and cannot easily move back across the renal epithelium. This leads to a marked increase in drug ...
... (BOH) in the tubular lumen into the charged salt. (A-/B+) – The charged particle is lipid-insoluble and cannot easily move back across the renal epithelium. This leads to a marked increase in drug ...
Over-the-Counter Drugs
... Prilosec (generic name omeprazole) is another example of a drug marketed under various forms and names (see Table 2). A generic omeprazole was released several years ago, but because of legal issues surrounding the brand’s patent protection, the generic drug kept a higher price for a longer period t ...
... Prilosec (generic name omeprazole) is another example of a drug marketed under various forms and names (see Table 2). A generic omeprazole was released several years ago, but because of legal issues surrounding the brand’s patent protection, the generic drug kept a higher price for a longer period t ...
Pharmacokinetics - Christopher Hobbs
... irreversible inhibition of the cytochrome P450 enzyme, CYP3A4 – resulting in an increase in systemic exposure, leading to adverse drug reactions and toxicity – flavonoids in grapefruit juice, naringin and hesperidin, reduce bioavailability of some drugs (Dolton et al. 2012). – Inhibition of CYP3A4 i ...
... irreversible inhibition of the cytochrome P450 enzyme, CYP3A4 – resulting in an increase in systemic exposure, leading to adverse drug reactions and toxicity – flavonoids in grapefruit juice, naringin and hesperidin, reduce bioavailability of some drugs (Dolton et al. 2012). – Inhibition of CYP3A4 i ...
File - medsays
... the urine, and perform the antisepic action in the bladder o These drugs have little or no systemic antibacterial effect ...
... the urine, and perform the antisepic action in the bladder o These drugs have little or no systemic antibacterial effect ...
4-Metabolic & NA Inhibitor(Lec.1&2)
... Enter into a normal metabolic pathway, but then block that pathway ...
... Enter into a normal metabolic pathway, but then block that pathway ...
Ursodiol
... pain and asthenia (1 patient), nausea (3 patients), dyspepsia (2 patients) and anorexia and esophagitis (1 patient each). One patient on the twice a day regimen (total dose 1000 mg) withdrew due to nausea. All of these nine adverse reactions except esophagitis were observed with the twice a day regi ...
... pain and asthenia (1 patient), nausea (3 patients), dyspepsia (2 patients) and anorexia and esophagitis (1 patient each). One patient on the twice a day regimen (total dose 1000 mg) withdrew due to nausea. All of these nine adverse reactions except esophagitis were observed with the twice a day regi ...
Discovery and development of proton pump inhibitors
Proton pump inhibitors (PPIs) block the gastric hydrogen potassium ATPase (H+,K+-ATPase) and inhibit gastric acid secretion. These drugs have emerged as the treatment of choice for acid-related diseases, including gastroesophageal reflux disease (GERD) and peptic ulcer disease.PPIs also can bind to other types of proton pumps such as those that occur in cancer cells and are finding applications in the reduction of cancer cell acid efflux and reduction of chemotherapy drug resistance.